Literature DB >> 17513935

Intrauterine growth restriction: how to manage and when to deliver.

Giancarlo Mari1, Farhan Hanif.   

Abstract

Intrauterine growth restriction secondary to placental insufficiency is a major cause of perinatal morbidity and mortality in the United States. Once intrauterine growth restriction is identified, obstetrical management is focused on assuring safety while the fetus continues to mature within a potentially hostile intrauterine environment. In the United States, the approach to management and delivery of the premature growth-restricted fetus is often based on serial biophysical profile evaluations, whereas in Europe it is usually based on the results of cardiotocography. However, there is no single test that seems superior to the other available tests for timing the delivery of the growth-restricted fetus. Therefore, the decision to deliver a fetus, especially at <32 weeks, remains mostly on the basis of empirical management.

Entities:  

Mesh:

Year:  2007        PMID: 17513935     DOI: 10.1097/GRF.0b013e31804c96a9

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  13 in total

1.  Parenteral administration of L-arginine prevents fetal growth restriction in undernourished ewes.

Authors:  Arantzatzu Lassala; Fuller W Bazer; Timothy A Cudd; Sujay Datta; Duane H Keisler; M Carey Satterfield; Thomas E Spencer; Guoyao Wu
Journal:  J Nutr       Date:  2010-05-26       Impact factor: 4.798

Review 2.  Sleep Disordered Breathing, a Novel, Modifiable Risk Factor for Hypertensive Disorders of Pregnancy.

Authors:  Laura Sanapo; Margaret H Bublitz; Ghada Bourjeily
Journal:  Curr Hypertens Rep       Date:  2020-03-12       Impact factor: 5.369

3.  Snoring during pregnancy and delivery outcomes: a cohort study.

Authors:  Louise M O'Brien; Alexandra S Bullough; Jocelynn T Owusu; Kimberley A Tremblay; Cynthia A Brincat; Mark C Chames; John D Kalbfleisch; Ronald D Chervin
Journal:  Sleep       Date:  2013-11-01       Impact factor: 5.849

4.  Obstetrical intervention and the singleton preterm birth rate in the United States from 1991-2006.

Authors:  Marian F MacDorman; Eugene Declercq; Jun Zhang
Journal:  Am J Public Health       Date:  2010-09-23       Impact factor: 9.308

Review 5.  Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?

Authors:  Guilherme R de Jesús; Gustavo Rodrigues; Nilson R de Jesús; Roger A Levy
Journal:  Curr Rheumatol Rep       Date:  2014-02       Impact factor: 4.592

6.  Effect of l-Arginine on Nitric Oxide Levels in Intrauterine Growth Restriction and its Correlation with Fetal Outcome.

Authors:  Shalini Singh; Archana Singh; Deepika Sharma; Abha Singh; M K Narula; Jayashree Bhattacharjee
Journal:  Indian J Clin Biochem       Date:  2014-07-15

7.  Gestational nanomaterial exposures: microvascular implications during pregnancy, fetal development and adulthood.

Authors:  P A Stapleton
Journal:  J Physiol       Date:  2015-10-28       Impact factor: 5.182

8.  Maternal hemoglobin level and fetal outcome at low and high altitudes.

Authors:  Gustavo F Gonzales; Kyle Steenland; Vilma Tapia
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-09-09       Impact factor: 3.619

9.  Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology.

Authors:  Brian Cox; Max Kotlyar; Andreas I Evangelou; Vladimir Ignatchenko; Alex Ignatchenko; Kathie Whiteley; Igor Jurisica; S Lee Adamson; Janet Rossant; Thomas Kislinger
Journal:  Mol Syst Biol       Date:  2009-06-16       Impact factor: 11.429

10.  Sleep Apnea and Fetal Growth Restriction (SAFER) study: protocol for a pragmatic randomised clinical trial of positive airway pressure as an antenatal therapy for fetal growth restriction in maternal obstructive sleep apnoea.

Authors:  Alex Hincker; Jacob Nadler; Suzanne Karan; Ebony Carter; Shay Porat; Barbara Warner; Yo-El S Ju; Arbi Ben Abdallah; Elizabeth Wilson; Ellen M Lockhart; Yehuda Ginosar
Journal:  BMJ Open       Date:  2021-06-29       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.